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SOMMARIO
Una delle piu` promettenti recenti innovazioni tecnologiche nella terapia del diabete sono i
dispositivi per il monitoraggio quasi continuo della glicemia (CGM). Questi piccoli sensori
sottocutanei rendono disponibile una grande mole di dati, prima inacessibile, il cui utilizzo
consente a paziente e diabetologo di migliorare significativamente la qualita` del controllo
glicemica. Questa tecnologia ha rinnovato l’intresse verso l’implementazione di un dispositivo
per il controllo automatico in catena chiusa della glicemia (Pancras Artificiale), che grazie ad
essa puo` diventare finalmente portatile e minimamente invasivo.
-
Un’altra tecnologia chiave nel campo per lo sviluppo del Pancreas Aritficiale e` il simulatore
del paziente diabetico, uno strumento software che consente di evitare i lunghi e dispendiosi
trial sugli animali, una volta necessari prima di testare un dispositivo sugli esseri umani.
Visto il ruolo sempre piu` cruciale delle simulazioni in questo settore, e` importante poter includere
in queste gli errori ed i faults a cui sono soggetti i dispositivi CGM cosı` da testare la robustezza
degli algoritmi a questi eventi e la loro efficacia nel gestirli.
-
Questa tesi si propone di rispondere alla necessita` di modelli per gli errori e i faults che
comunemente si riscontrano nei dati CGM reali, da utilizzare nei test simulati di robustezza.
-
Dall’osservazione di un data set fornito da misure con sensori CGM Dexcom® (Capitolo 2)
sono stati individuate tre classi di errori e per ciascuna di queste e` stato proposto un modello e
un modulo di simulazione. Le disconnessioni (Capitolo 3) consistono nella perdita di almeno un
campione, a causa di un malfunzionamento della comunicazione tra i componenti trasmissivi e
ricettivi del sensore. Un modello di Markov a due stati e` stato proposto e validato. Gli errori
di tipo segnale non valido (Capitolo 4) sono stati associati all’indicazione del ricevitore pari a
9 o 10 mg/dl. Per questo tipo di errore un modello di Markov a due stati non e` stato sufficiente
a descrivere l’intera casistica, che comprende errori di breve durata (meno di un’ora) e di lunga
durata (alcune ore). Infine, un terzo tipo di errore e` assimilabile ad una perdita di sensitivita`
del sensore, a causa di una pressione sullo stesso. Il modello proposto e validato (Capitolo 5)
consiste nell’assimilare tale errore ad una funzione gradino filtrato da un sistema dinamico del
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primo ordine.
Per gli errori di disconnessione e di perdita di sensitivita` e` stato possibile quindi proporre due
moduli di simulazione che permettono di avvicinare i profili glicemici simulati a quelli ottenuti
da misurazioni reali con sensori CGM; nel caso degli errori di tipo ‘segnale non valido’ la
simulazione e` stata avviata sfruttando l’informazione statistica empirica dei dati (Capitolo 6).
SUMMARY
One of the most promising recent technological innovation in diabetes management are the
devices for continuous glucose monitoring (CGM). These small subcutaneous sensors give
us a large amount of information that was inaccessible before. Using these sensors allows
both patient and diabetologist to significantly improve the quality of the closed loop control of
glycemic levels. This technology has renewed the interest in the development of a device for
closed loop automatic control of glycemia (Artificial Pancreas), that can eventually be wearable
and minimally invasive.
-
Another key technology for the Artificial Pancreas development is the physiological simu-
lator of a diabetic patient, a software tool that allows to avoid expensive and time consuming
trials on animals, that once were necessary in order to test any device for human beings.
Since simulation is becoming more and more crucial in this field, it is important to involve the
most common failures that affects CGM devices, so that algorithms’ robustness to these events
can be tested together with their skill in managing them.
-
This thesis is meant to meet the need for models of the most common failures which can be
used for robustness simulated tests.
-
The observation of a data set of Dexcom® CGM measurements (Chapter 2) led us to
identify three kinds of failures and for each one of them a model was proposed. Disconnections
consists of the loss of at least one sample, caused by the interruption of communications between
transmitter and receiver. A two-state Markov model was proposed and validated. Invalid Outputs
(Chapter 4) were associated with the received CGM readings of 9 or 10 mg/dl. In this case, the
two-state Markov model was not suitable for the description of both short (less than one hour)
and long-lasting (several hours) failures. Lastly, a third kind of failure was classified as a loss of
sensitivity of the sensor, caused by a pressure on the sensor itself. The model, that was proposed
and validated (Chapter 5), described this failure as a step function filtered by a first order system.
For what concerns disconnections and losses of sensitivity we could build simulation tools that
allow us to make simulated glyceimic profiles more similar to the real ones. In order to simulate
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invalid outputs, the simulation was run with the empirical statistical information (Chapter 6).
1
Diabetes and Continuous Glucose Monitoring
Diabetes Mellitus is a metabolic disease characterized by either the insufficient produc-
tion of the insulin hormon to maintain the glucose level in the normal range (Type-1
diabetes), which is usually set between 70 and 180 mg/dl, or the inability of the body
to respond to the insulin formed within the system (Type-2 diabetes). To cover this
deficiency, conventional approach is to introduce insulin with subcutaneous injections.
In order to determine the proper dosage for their insulin injections patients have to
frequently monitor their blood glucose concentration by means of Self Monitoring Blood
Glucose (SMBG) therapy (i.e. 3-4 finger stick measurements per day). In the last few
years new sensors have been developed, allowing Continuous Glucose Monitoring
(CGM), e.g. a glucose measurement is obtained every 5 minutes and for several
days. These devices significantly improve diabetes management detecting more critical
episodes (i.e. hypo and hyperglycemia) rather than conventional SMBG.
In this chapter Diabetes and related complications, SMBG and devices for CGM will be
briefly introduced and described.
1.1 Diabetes Pathophysiology
Glucose is the main power source for the organism, and its concentration in blood circulation is
characterized by a dynamic equilibrium between its production and utilization.
Normally, the organism receives the amount of glucose he needs from food, while liver and
kidneys supply it in case of short fasting. In a healthy person, glycemia is accurately regulated
by the organism, and insulin, produced by pancreas, is the crucial hormon in glucose metabolism.
Diabetes is a chronic disease that occurs either when the pancreas does not produce enough
insulin or when the body cannot effectively use the insulin it produces. Hyperglycaemia, or
raised blood sugar, is a common effect of uncontrolled diabetes and over time leads to serious
damage to many of the body’s systems, especially the nerves and blood vessels.
Diabetes is classified into two types:
1
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1. Type-1 diabetes mellitus (T1DM): previously known as insulin-dependent, juvenile or
childhood-onset, is characterized by deficient insulin production and requires daily ad-
ministration of insulin. The cause of type 1 diabetes is not known and it is not preventable
with current knowledge.
Symptoms include excessive excretion of urine (polyuria), thirst (polydipsia), constant
hunger, weight loss, vision changes and fatigue. These symptoms may occur suddenly.
2. Type-2 diabetes mellitus (T2DM): formerly called non-insulin-dependent or adult-onset,
results from the body’s ineffective use of insulin. Type 2 diabetes comprises 90% of
people with diabetes around the world, and is largely the result of excess body weight and
physical inactivity.
Symptoms may be similar to those of Type 1 diabetes, but are often less marked. As a
result, the disease may be diagnosed several years after onset, once complications have
already arisen. Until recently, this type of diabetes was seen only in adults but it is now
also occurring in children.
1.2 Glucose monitoring and Diabetes Therapy
Diabetes therapy’s aim is that of keeping glucose levels in the euglycemic range (70-180 mg/dl),
so as to minimize or at least delay diabetes complications: over time, diabetes can damage
the heart, blood vessels, eyes, kidneys and nerves. At present, diabetes conventional therapy
relies on insulin and drug administration, diet and physical exercise: people with T1DM require
insulin, while people with T2DM may not need it and can be treated with oral medication. Until
the fifties insulin dosage was determined without considering real glucose levels of the patient.
Setting insulin dosage is a challenging subject, and starting from the eighties this decision was
up to new devices and technologies that could help Self Monitoring Blood Glucose (SMBG).
A typical SMBG test includes a drop of blood, obtained via a finger prick and applied to a
chemically treated reagent strip, which is analyzed by the device. The test provides discrete and
highly accurate data about current blood glucose levels. Insulin administrations rely then on
three or four measures of blood glucose level per day: accuracy of the therapy is user-dependent,
i.e. patients should be taught how to modify their food intake and therapy according to the
SMBG data and in order to realize their individual glycemic goals. The insulin therapy then can
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Figure 1.1 Comparison between CGM data (red profile) and SMBG measurements (blue
dots). The green area shows the normal range of blood glucose.
be administered in two ways:
Multiple injection regimen: multiple daily subcutaneous injection are perfomed with sy-
ringes. Injection sites are the tissue of the upper arm and the anterior and lateral aspects of the
thigh, buttocks, and abdomen. Short acting insulin should be injected within 30 min before a
meal or immediately after a meal, in order to oppose the quick rise of the glycemic level due to
the food intake, while Long acting insulin are administered to provide a basal insulinemia.
Continuous subcutaneous insulin infusion (CSII): a subcutaneous infusion pump injects
of short acting insulin, delivered via a needle or a catheter sited under the skin and connected to
a reservoir of insulin and a command module. This therapy is aimed at replacing long acting
insulin for basal needs, continuously delivering short acting micro boli of insulin. However,
insulin pumps are expensive, and at present they are available to a little amount of patients.
-
Nonetheless, the few SMBG samples do not give us enough information about critical
glycemic episodes, e.g postprandial hypoglycemia and hyperglycemia. We find an example of
this drawback in Figure 1.1. The several SMBG measurements performed (blue dots) could not
catch three episodes of severe hyperglycemia and two of mild hypoglycemia, which are instead
highlighted by the real glycemia data (red profile) and its excursions outside the range of normal
glucose level (green area).
The SMBG inefficiency to identify all glucose excursions out of the euglycemic range,
together with the pain associated with finger pricking, led during the last decade to the de-
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velopment of new electronic devices that allow a quasi-continuous and minimally-invasive
measurement of blood glucose concentrations, the so-called Continuous Glucose Monitoring
(CGM) wearable systems. CGM measurements provide relevant information about the diabetes
of a patient, and the importance of this technology will be discussed in Section 1.3.3, together
with its drawbacks.
1.3 CGM sensors
Continuous glucose monitoring systems are electronic devices that measure physiological
glucose levels. Glucose readings are provided every 1 to 5 minutes for several days (up to 7
days). Usually the device is made of a glucose sensor, that measures glucose levels of blood or
interstitial fluid, and a wireless (or wired) transmitter which communicates glucose readings
to a receiver that displays the current glucose data. CGM devices enable the identification of
the overall trend in the glucose level, and based on these trends, proximal glucose levels can
be forecast, along with hypo and hyperglycemia. The retrospective analysis of CGM direction,
frequency and magnitude supply trend information that assists in optimizing treatment plans,
adapting insulin regimens and facilitating clinical decisions.
Depending on the placement of the glucose sensor, we can define the degree of invasiveness
of a CGM device. From this point of view, they can be classified into two groups: minimally-
invasive and non-invasive devices.
1.3.1 Minimally-Invasive Devices
The minimally-invasive technologies measure glucose concentrations in the subcutaneous
tissue, where the sensor is partially sited. Hence this classification describes the fact that the
measurement does not draw from any blood vessel, but yet it compromises the skin barrier.
This type of CGM systems is usually made of two components: a subcutaneous glucose
sensor implanted on patient’s skin, which provides measurements of the interstitial glucose
concentration and is also a transmitter, and a small device that receives, stores and visualizes
CGM data.
The subcutaneous sensor can be based on different principles, e.g. microneedle technology
is made of silicon micro-needles that penetrate the skin and draw small samples of blood, while
micropore technology employs laser ablation to create microscopic holes on the outmost layer
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of the epidermis and draws interstitial fluid samples with a small local vacuum (for a complete
review of current technologies see [2]). From a glucose detection technology point of view,
most of the minimally-invasive sensors exploit a glucose-oxidase reaction to measure a raw
signal, proportional to the glucose concentration of the site in which the biosensor is sited, i.e.
in this case the interstitial tissue. This signal is usually a current given in mA. In order to read
glucose leveles in mg/dl, a calibration procedure is then to be performed, using one or more
SMBG samples. Some of the most important minimally-invasive CGM devices are:
• CGM System Gold (CGMS® System Gold™ Medtronic MiniMed, Northridge, CA,
USA), FDA approved in March 2001 [19];
• GlucoDay® (A. Menarini Diagnostics, Florence, Italy), which received CE mark in
Europe [20];
• Guardian® Real-Time (Medtronic MiniMed, Northridge, CA, USA), FDA approved in
June 2005 [21];
• FreeStyle Navigator™ (Abbott Laboratories, Alameda, CA, USA), FDA approved in
March 2008 [22];
• Seven® Plus (DexCom, San Diego, CA, USA), FDA approved in February 2009 [23]
The DexCom® Seven® Plus CGM system, which provided the data we analyzed in this
thesis, will be talked out in Section 1.4.
1.3.2 Non-Invasive Devices
The need to avoid wounds and risk of infection from penetrating the skin has led to the
challenging development of non-invasive sensors that measure glucose concentration from
external body fluids assesment, such as saliva and tears [5], or with transdermal sensor based
on optical approach. Focusing on the latter, the exploited detection technologies can involve
fluorophores and thus measure Forster Resonance Energy Transfer (FRET) lifetime or intensity.
Other optical techniques that do not use glucose-binding-fluorophore are e.g. Near Infrared
(NIR) kromoscopy, Raman spectroscopy, polarimetry, photoacoustic spectroscopy and optical
coherence tomography.
This kind of glucose monitoring is very promising, yet it will require several years before
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reaching the market place. This is mainly due to many drawbacks concerning accuracy, precision
and selectivity, i.e. the ability of the sensor to respond only to changes in glucose within the
pool of molecules present in the body, like albumin and ascorbic acid.
Hereafter some intersting non-invasive sensors are briefly discussed:
• The NBM (OrSense Ltd., Nes Ziona, Israel) device is a prototype, and is based on
occlusion spectroscopy [3]. The measurement is performed using an annular probe,
which is positioned on the finger’s root. The probe contains light sources and detectors
operating in the red/near-infrared (RNIR) spectral region and pneumatic cuffs that produce
oversystolic pressure to occlude blood flow. The occlusion of blood flow generates a
dynamic optical signal, which facilitates accurate glucose monitoring. The technology is
based on the direct effect of glucose on the scattering properties of the organ. Glucose
decreases the mismatch in refractive index between scatterers and their surrounding media,
leading to a smaller scattering coefficient and, consequently, a shorter optical path. As
a result, with the growing concentration of glucose, fewer photons are absorbed and
the light intensity increases. Development of this device is focused on improving the
performance and ease of use in the home-use setting.
• The Solianis Multisensor (Biovotion AG, Zu¨rich, CH) device uses impedance spec-
troscopy in order to measure glucose levels [4, 18]. The principle of glucose detection
using this technology is: an increase in the local glucose concentration results in a de-
crease in the sodium levels and an increase in the potassium levels of the plasma, changing
the dielectric strength, permittivity and conductivity of the plasma.
• The HG1-c nCGM (C8 MediSensors Inc., San Jose, CA, USA) is an investigational
device, not cleared or approved for marketing in any jurisdiction [24]. This non-invasive
CGM uses a light-sensitive sensor when detecting body’s glucose levels and sends glucose
measurements to a smart phone or any other compatible display device. It exploits Raman
spectroscopy: the colours generated by Raman scattering, induced by illumination of a
sample, are very specific to the exact chemical structure of molecules in the sample. Since
glucose has its unique spectral fingerprint, it can be non-invasively measured beneath the
skin.
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1.3.3 Pros and Cons of CGM Devices
CGM devices have the great advantage to supply to both clinicians and diabetic patients a
more complete information about the glycemic profile rather than SMBG. The possibility to have
real-time information about the glycemic level and its trend is very useful in the management of
patient’s therapy, e.g. in the adjustment of the diet and the insulin dosage. Another significant
improvement in diabetes management is also represented by the embedding in many of the
CGM system of a tool able to generate visual and acoustic alerts when glucose concentration
exceeds the normal range thresholds.
The portability of these devices and the possibility to receive an alarm when some fixed glycemic
thresholds have been crossed, allow the diabetic patient to become more self-sufficient in the
management of both therapy and critical events, e.g. post-prandial hyperglycemia and nocturnal
hypoglycemia.
It is also important to remind that, nowadays, none of the CGM devices has been approved
to substitute SMBG as reference in both control and management of the therapy. This fact is
principally due to the lack of accuracy of CGM readings, accuracy which is crucial for the
correct working of such a devices. Another critical topic with all CGM systems is calibration,
i.e. relying on the glucose signal measured in interstitial fluid to blood glucose by means of
capillary blood glucose measurements. For instance, if this is performed while blood glucose
changes rapidly or if this is not performed with sufficient frequency to compensate for drift,
there might be an unnecessary difference between measured and real glucose levels.
1.4 Dexcom® SEVEN® PLUS
The SEVEN® PLUS CGM System is a glucose-monitoring device for detecting glucose trends in
adults with diabetes, and it is not approved for use on people aged less than 18, pregnant women
or people on dialysis. The system received FDA approval for up to 7 days of use, although it is
not designed to replace standard home glucose monitoring devices. Its use is helpful in order to
detect hypoglycemic events, since it emits an alarm if the measured concentration of glucose
reaches or goes under 55 mg/dl. The performances of the sensor were evaluated only for one
probe insertion site, which is the skin of the abdomen [23].
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Figure 1.2 Components of the SEVEN® PLUS System: on the left the Receiver,a cell-phone
sized device programmed to collect and process data from the sensor and to display the results
as a glucose values, in the middle the Sensor with the Transmitter, on the right the Sensor with
the applicator, used to insert the probe underneath the skin.
1.4.1 System components
The SEVEN® system consists of three major components.
1. The Sensor, sterilized by electron beam and made up of three parts
• Applicator: a disposable piece of the Sensor that you use to insert the Sensor Probe.
There is a needle inside the Applicator that is removed once the Sensor Probe is
inserted underneath the skin.
• Sensor Probe: is the portion of the sensor that is actually inserted under the skin and
measures glucose levels of the interstitial fluid in the sorroundings of the area in
which it is inserted.
• Sensor Pod: it sticks to the abdomen and holds the Transmitter in place. The Sensor
Pod and the Transmitter are the only components that are actually worn by the
patient during the glucose monitoring session.
2. The Transmitter, which snaps into the Sensor Pod and wirelessly sends glucose data to
the Receiver.
3. The Receiver, a cell-phone sized device programmed to collect and process data from the
Sensor and to display the results as a glucose value. Values above 400 mg/dl or below
39 mg/dl are not shown by the display.
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1.4.2 Principle of operation
The SEVEN® PLUS Sensor exploits an electrochemical reaction with glucose. The reagent
used is glucose oxidase, obtained from a microorganism, and less than 0.4 µg is applied to each
Sensor Probe (for a further insight into enzyme for glucose monitoring applications see [7]).
The Sensor Probe is a round platinum electrode with a multi-layered membrane technology. The
reaction allows glucose to be converted into an electronic signal [2], which is sent wirelessly via
radio frequency (RF) to the Receiver by the Transmitter, with an average lag time of 5 minutes.
The Receiver converts the signal to a glucose reading that is displayed to the user.
1.5 Aim of the Work and Outline
In the previous Sections we have discussed capabilities and drawbacks of CGM devices. The
aim of this work is to classify, analyze and model three of the most common transient failures
we have found in CGM readings we were provided, in order to eventually simulate them.
-
Chapter 2 consists of the description of the two data sets we were provided and on which
we led our investigation.
-
Chapter 3 is dedicated to the first kind of fault we have found and analyzed, and we called
it disconnection. This failure is due to the loss of at least one sample from CGM readings for
technological reasons. The collected set of disconnections was statistically investigated, and a
model was proposed and validated.
-
Chapter 4 illustrates the second kind of fault we have found, and we called it invaid output.
This failure can be read as an ‘error code’ of the CGM signal, since the receiver displays a
glycemic level of 9 or 10 mg/dl. Along with a statistical investigation of the invalid outputs we
have detected, a model was proposed and demonstrated to be acceptable for short-lasting invalid
outputs.
-
Chapter 5 is the core of this work, and shows the most interesting results. The subject of
this Chapter is the analysis of a third kind of failure, that we have called loss of sensitivity of the
10 Chapter 1. Diabetes and Continuous Glucose Monitoring
CGM signal. This fault is not well-rendered like the other two, so it is important to detect it and
model it. Losses of sensitivity are due to a transitional pressure applied to the sensor that acts
as a low pass filter. Hence, a good model for this kind of failure is to consider it as a disturb
consisting of a step function filtered by a first order system. The model we have proposed was
eventually validated.
-
Chapter 6 shows the simulated transient failures with the previously discussed models, with
an application on simulated CGM profiles.
2
Features of the two datasets
In this chapter we will describe the two datasets available for modeling CGM faults. Both
the datasets were obtained with Dexcom® SEVEN® PLUS CGM sensors discussed
in chapter 1, in two different trials overall. We were provided with 94 CGM signals on
the whole, each of them lasting 7 days on average. For some shorter period frequent
BG samples were also available, and this information can be exploited to classify faulty
measurements.
2.1 First dataset
The first dataset we have taken into account is collected by the Artificial Pancreas (AP) at home
consortium. AP@home is an European research project funded by the European commission;
its aim is to improve treatment of patients with diabetes at home by enhancing closed-loop
algorithms for artificial pancreas (AP) system that can be used in daily practice. For a description
of the basic strategy that the European consortium AP@home plans to follow in its attempt to
develop an artificial pancreas system see [6, 25].
2.1.1 Study design
The study is a multinational open-label trial involving four Clinical Research Centres (CRC),
reported in Table 2.1. Sensor data were collected over the course of a 7 day period most of
which are in an outpatient setting; patients visited CRC on day 1 and day 7 for insertion and
removal of the two Dexcom® SEVEN® PLUS CGM sensors and on day 3 for Blood Glucose
(BG) measurements. Both sensors were calibrated right after the insertion, but then underwent
different calibration schedules, in order to compare the built-in calibration of the sensor with
the recalibration algorithms developed for the smart sensor, i.e. a CGM sensor provided with
algorithms able to generate alerts when glucose concentration is predicted to exceed the normal
range threshold [8].
Reference blood glucose samples were gathered during study day 3, from 7pm to 4pm of
11
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Academic Medical Centre Amsterdam The Netherlands, EU
Medical University Graz Austria, EU
Profile Institute for Metabolic Research GmbH Germany, EU
University of Padua Italy, EU
Table 2.1 European centres involved in the study
the day after. Blood samples were drawn every 15 minutes during the day and every 2 hours
during the night; all blood samples were analyzed using the blood glucose Analyzer from Yellow
Spring Instruments (YSI) laboratories. This kind of information is useful to our purposes as it
allows us to classify as faulty some CGM samples with a higher rate of certainty.
2.1.2 Subject demographics
This study included 12 patients with T1DM, 3 in each of the four participating clinical centres
of the consortium; all of them were aged at least 18 years, treated by basal-bolus insulin therapy
using Continuous Subcutaneous Insulin Infusion (CSII) for at least 3 months and trained in
carbohydrate counting; lastly, Body Mass Index (BMI) lower than 35 kg/m2 was an inclusion
criterion.
Furthermore, pregnant or breast feeding patients were not admitted to the study, nor patients with
a history of myocardial infarction, acute coronary sindrome, therapeutic coronary intervention
and coronary bypass.
Since 2 CGM sensors were inserted in each patient and one patient had withdrawn, we could
observe 22 signals from this first dataset. Figure 2.1 displays an example of the data collected in
Germany (see Table 2.1).
2.2 Second dataset
The second dataset that we used is the one considered in [1]: the aim of the study was to evaluate
whether continuous glucose monitor alerts are capable of both detecting and predicting low and
high BG events.
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Figure 2.1 CGM data from the 2 sensors on one patient (patient #1 in Germany). Time
flowing is measured from the insertion of the sensor.
2.2.1 Study design
Each subject wore the Dexcom® SEVEN® PLUS CGM sensor for 7 days and underwent an
8-hour in-clinic session on day 1, 4, or 7. During the in-clinic session, venous plasma samples
were taken every 15 minutes with a Yellow Springs Instruments (YSI)-2300. Patients involved
in the study were instructed to calibrate the sensor twice per day with a BG meter.
2.2.2 Subject demographics
CGM and reference BG data were collected from 53 adults with insulin-dependent diabetes,
81% of them affected by T1DM. These patients were gathered across three sites within the
United States, and wore 72 sensors: 18 people wore 2 sensors, 35 people wore 1 sensor and 1
sensor was replaced.
The mean age of patients is 47.3 years old, with a standard deviation of 12.4; 22 subjects
were female (42%), 50 were Caucasian (94%), 26 delivered insulin via multiple daily injections
and their mean BMI was 27.9kg/m2 with 7.7 as standard deviation.
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Figure 2.2 CGM data from the sensor on two different patients. Time flowing is measured
from the insertion of the sensor. The square markers reveal calibration events.
3
Analysis of the disconnection fault
In the previous chapter the two datasets have been described. We have shown that
the signals were approximately seven-days lasting data, with a sampling period of
5 minutes. BG samples were also gathered for a shorter period of time during the
CGM measurement, usually for 24 hours. In fact, BG measurement requires invasive
treatment that needs to be done in the hospital, where patients were admitted for short
periods of time during CGM monitoring. We investigated the CGM data in order to
detect any dysfunctional behaviour of the sensors with no forecast for the shapes we
would find, using BG as a reference when available.
The first kind of fault is hereinafter discussed, together with its main features and stastis-
tical parameters, gathered for simulation purposes. We will refer to it as disconnection.
This type of error consists of the loss of at least one sample, and it is detected by
investigating time occurances of the data. We found 3868 disconnections overall.
3.1 Disconnections
As discussed in Section 1.4, the SEVEN® PLUS Transimitter, mounted on the Sensor, sends
the glucose readings to the Receiver every 5 minutes approximately. If we find out that the
lag between two adjacent samples is significantly larger than 5 minutes, then we can state that
an error had occured, as shown in Figure 3.1. We shall call disconnection this type of fault,
since Transmitter and Receiver seem to interrupt their wireless communications for at least one
sample.
We consider this type of fault mainly due to a pure technological error of the sensor or to a
bad management of the sensor for a short period. This is why we chose not to include in our
analysis faulty intervals larger than 75 minutes, believing that if the signal is missing for a larger
interval it means that the patient has surely forgotten to keep the Receiver within the proper
radius. We cannot ignore that our decision is a critical topic and should be investigated taking
into account an analysis of patients’ compliance.
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Figure 3.1 The tips define two examples of disconnection fault. The X-coordinate displayed
by the labels is measured in minutes and show the faulty distance between two samples in a row.
All the 94 CGM signals described in Chapter 2 were considered in this first analysis. In
order to detect the errors, we investigated time occurrences of the data, by verifying if the lag
between one sample and the next was approximately equal to the sampling period of the sensor.
If this was not true, i.e we chose a 7-minutes minimum lag, we considered the interval between
the two samples as faulty, meaning that some data had got lost. With this isolation procedure,
3868 disconnections have been found.
For each detected fault we recorded its beginning and length, both measured in minutes from
the midnight of the day of insertion of the sensor. This information was then considered in a
statistical approach, as described later on in Sections 3.2, 3.5.1 and 3.5.2.
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Figure 3.2 Histogram of the number of lost samples due to disconnection error. The ordinate
is logarithmically scaled.
3.2 Duration of disconnections
As discussed in Section 3.1, we defined an upper bound to the length of the errors we were
detecting, i.e. the maximum length of a disconnection is of 75 minutes. Figure 3.2 shows
the histogram of the several lengths of the disconnections overall. In the abscissa we read the
number of samples that are missing in the faulty interval, i.e. if we detect a 10-minutes lag
between two samples in a row, that means that 1 sample had gone lost.
The highest number of disconnections consists in a loss of 1 sample (2875), and the
histogram suggests that durations exponentially decrease. On average, a disconnection consists
in the loss of 1.54 samples with a standard deviation of 1.2 samples (12.7055 minutes, with
a standard deviation of 6.4075 minutes), while mode and median coincide at 1 sample (10
minutes).
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Figure 3.3 Two-state Markov model for disconnections.
3.3 Data modeling
In this Section we propose a reasonable model for the CGM signal with which we can explain
the disconnection fault and we will show in Section 3.4 that our idea justified. CGM sensor
functioning can be modelled with a two-state Markov chain. A Markov chain is a mathematical
system that undergoes transitions from one state to another according to certain probabilities
(called transition probabilities), between a finite or countable number of possible states. The
“system” is a random process characterized as memoryless: the next state depends only on
the current state and not on the sequence of events that preceded it. This specific kind of
memorylessness is called Markov property.
Figure 3.3 shows the two-state Markov chain we consider in order to explain the transition
from the regularly working state (R) to a faulty state (F). Every regular sample is followed by
a faulty one with probability α, or by a regular one with probability 1− α, while every faulty
sample is followed by another faulty sample with probability β, or by a regular sample with
probability 1− β.
3.3.1 Estimate of α
The transition probability α corresponds to the probability of a faulty sample to succeed a
regular one. i.e. it allows us to compute when a failure occurs. It is estimated as follows:
αˆ =
# detected faults
# samples observed overall - #faulty samples
. (3.1)
The estimated value is αˆ = 0.0230.
3.3.2 Estimate of β
The transition probability β corresponds to the probability of a faulty sample to succeed another
faulty sample, i.e. it allows us to compute the duration of the failure once it has already started.
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Given that N is the number of possible durations we found in the statistical analisys 3.2, we can
compute N − 1 probabilities that a disconnection that lasted i samples, lasts i+ 1 samples. We
shall define this probability as:
βˆi =
#[d ≥ i+ 1]
#[d ≥ i] , i = 1, . . . , N − 1. (3.2)
Assuming that the probability to remain in the faulty state does not depend on the duration of a
disconnection, we can evaluate an average value for the transition probability β as follows:
βˆ =
1
N
N∑
i=1
βˆi. (3.3)
The estimated value is βˆ = 0.5665.
Nevertheless, we can choose to rely mostly in shorter disconnections, where the sample is
larger, and compute the value for the transition probability β e.g. averaging only the first three
values of the {βˆi} set, or the first seven values of the {βˆi} set:
βˆ3 =
1
3
3∑
i=1
βˆi, βˆ7 =
1
7
7∑
i=1
βˆi. (3.4)
We will show in Section 3.4 which one of the three proposed values for β is the most appropriate,
but we have to point out that some other options are also available and not taken into account in
this work: for example, averaging among the {βˆi} can be done with a matrix that weights the
values differently according to their reliability.
The estimated values for the probabilities defined in Equation 3.4 are βˆ3 = 0.4377 and βˆ7 =
0.5126.
3.4 Validation
Observing the Markov chain described in Section 3.3 we can state that the probability for a
disconnection to last at least one sample is the transition probability α. Then, the probability for
a disconnection to last at least two samples is the product of the probability to fall into the faulty
state, that is α, and the probability to remain in the faulty state for the next sample, that is β. We
can write this as follows:
P [d ≥ 1] = α
P [d ≥ 2] = αβ
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P [d ≥ 3] = αβ2
and by induction:
P [d ≥ n] = αβn−1
Nevertheless, from the histogram discussed in Section 3.2 we can evaluate probabilities
such as P[duration is equal to k samples]. Hence:
P [d ≥ k] = P [d = k ∪ d ≥ k + 1] = P [d = k] + P [d ≥ k + 1]
P [d = k] = P [d ≥ k]− P [d ≥ k + 1].
If we introduce α and β in the notation we find:
P [d = 1] = P [d ≥ 1]− P [d ≥ 2] = α− αβ = α(1− β)
P [d = 2] = P [d ≥ 2]− P [d ≥ 3] = αβ − αβ2 = αβ(1− β)
P [d = 3] = P [d ≥ 3]− P [d ≥ 4] = αβ2 − αβ3 = αβ2(1− β)
and by induction:
P [d = k] = α(1− β)βk−1.
Therefore we obtain:
logP [d = k] = log
α(1− β)
β
+ klogβ. (3.5)
Equation 3.5 can be read as the equation of a line, whose slope is logβ and y-intercept is
logα(1−β)β . Hence, transition probabilities α and β could be computed from the histogram in
Figure 3.2 as the defining parameters of the line whose equation is 3.5.
Figure 3.4 shows the result (blue line) if we draw the line with αˆ and βˆ estimated in 3.3.1
and 3.3.2. The red line and the green one correspond to the estimated parameters defined in
Equation 3.4. We can observe that the three lines fit more precisly the values of the histogram
for # lost samples = 1, where the sample is larger. The red line seem to fit more precisly overall
than the other two estimated lines, so our choice is to consider βˆ7 as the proper value for the
transition probability β.
3.5 Revising probabilities considering the day and the hour
We wonder if failures’ occurances depend on the hour of the day and on sensor day, i.e. the
moment from sensor insertion. In order to answer this question, we need to investigate whether
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Figure 3.4 Graphic validation of the model: the lines drawn with the estimated parameters
αˆ and βˆ fit the normalized histogram of disconnections’ durations. In the legend are displayed
the three estimated values of βˆ, depending on the confidence we have in the data.
failures occur evenly both during the several days and during the several hours of the day,
exploiting a statistical analysis, that is hereinafter discussed.
3.5.1 Time from insertion
In order to visualize how the disconnection event occurs during the experiment, we plotted
the information about the start of each fault using a histogram as shown in Figure 3.5.1. The
starting points were measured from the insertion of the sensor, thus we are here analyzing
sensor’s behaviour during sensor life. During our investigation we did not consider those pieces
of CGM signal which were recorded after the end of the 7-th day of trial: in fact, even though
the approval of the SEVEN PLUS sensor is for up to 7 days of monitoring, some monitoring
session ended late.
During day-5 we observe the highest number of errors (693), and they are distributed over
the several days of trial with a mean value of 483.5 disconnections per day, standard deviation
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Figure 3.5 Distribution of disconnections over the several trial days, with failures’ starting
points measured from the insertion of the sensor. Left panel: histogram, each day involves 2 bins
of 12 hours, Mean: 3.5242, stdev: 1.9744, median: 3.5979. Right panel: probability density
function obtained via kenel density estimation.
of 206.9 and median of 519.5. On day-1 we found 569 disconnections, and this is probably due
to the inaccuracy of the sensor at the beginning of its monitoring session. During day-4 and
day-5 we recorded the two highest amounts of errors: we can assume that in this phase of the
trial the patient might have relaxed his careful behaviour in the management of the sensor.
The right panel of Figure 3.5.1 shows the probability density function obtained with kernel
density estimation approach, described in Appendix A. The estimation was done at 120 equally
spaced points, with a bandwidth of the smoothing window of 0.3074.
3.5.2 Distribution over 24 hours
In Section 3.5.1 we have investigated the time occurances of disconnections with respect to
sensor life. Now we want to understand how disconnections occur during 24hours-periods.
Firstly, we considered every single day of the trial as a case study. The results, displayed in
Figure 3.5.2, show the probability density function, obtained via kernel density estimation (see
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Figure 3.6 Left panel: probability density functions for disconnections occurrences during
days #2, #3, #4, #5 and #7. Middle panel and right panel: probability density functions
for disconnections occurrences during days #1 and #6. The estimation is obtained via kernel
density estimation approach.4
Appendix A), of disconnections during the several days. The left panel of the Figure shows
five estimated probability density functions overlapped, corresponding to days #2, #3, #4,
#5 and #7. We can see that these five curves are quite similar, while middle and right panel
separately show the ones corresponding to days #1 and #6. The curve in the middle panel is
spoiled by the fact that the time of sensor insertion is different for every trial, while the curve in
the right panel is biased because many trials ended by the afternoon of the sixth day. For these
reasons, we are showing them separately, and we can conclude that for the other days there is
no significant variability between one day and the other. Hence, we chose to analyze an average
value of the distribution, obtained considering all days to be equivalent.
Considering every disconnection as if they occurred in one single day, we could observe
the distribution of the errors depending on the hour of the day. As shown by the histogram
in the left panel of Figure 3.5.2, the highest number of disconnections occurs at 6am (217),
and they are distributed over the 24hours with a mean value of 154.7 disconnections per hour,
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Figure 3.7 Distribution of disconnections over 24 hours. Left panel: histogram; mean:
11.4629, st dev: 7.1441, median: 10.8504. Right panel: probability density function estimated
via kernel density estimation approach.
standard deviation of 40.5 and median of 154.7. The histogram shows that the highest number
of disconnection occur during night-time (from 9pm to 8am). In this phase of the day, the patient
is more likely to be in the sorroundings of the receiver, so we can assume that disconnections are
probably mainly due to a technological failure of the sensor, rather than improper management
of the device.
In the right panel of Figure 3.5.2 is the probability density function obtained with kernel
density estimation approach (see Appendix A). The estimation was done at 120 equally spaced
points, with a bandwidth of the kernel smoothing window of 0.3489.
3.5.3 Revising transition probability α
According to Sections 3.5.1 and 3.5.2, failures do not occur evenly neither during the several
days nor during the several hours of the day. This remark suggest we should take into account
revising the transition probability α described in Section 3.3.1. The transition probability from
the regular-state to the faulty-state should depend also on the hour and the day of the week of
the current state.
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Hence, we look for the probability of a failure event, given the fact that the current day is
day, that is, with the use of Bayes’ rule:
P [f |DAY = day] = P [f ∩ DAY = day]
P [DAY = day]
=
P [DAY = day|f ]P [f ]
P [DAY = day]
.
From the histogram discussed in Section 3.5.1 we can compute P [DAY = day|f ], while P [f ]
is αˆ and P [DAY = day] is equal to 1/7. The probability we are looking for can be written as:
P [f |DAY = day] = 7 ·P [DAY = day|f ] · αˆ.
The same argument still holds for the case of the different distribution of disconnections over
the 24hours, therefore we can conclude that the transition probability α we are looking for is:
P [f |DAY = day, HOUR = hour] = 24 · 7 ·P [DAY = day|f ]P [HOUR = hour|f ] · αˆ. (3.6)

4
Analysis of the invalid output fault
After the analysis of a first type of error, the disconnection, we focus on a second type,
and we shall call it invalid output. The invalid output can be read as an ‘error code’ of
the CGM signal, since the receiver displays a glycemic level of 9 or 10 mg/dl.
We recorded time occurances of the errors, in order to analyze its main statistical
parameters for simulation purposes. Our investigation led us to find 173 invalid output
overall, and we discovered that only the signals from the data set 2.2 were corrupted
by this fault (72 CGM signals out of the 94 we were provided).
4.1 Invalid Outputs
As discussed in Section 1.4.1, the SEVEN® PLUS sensor does not display glucose values
outside the range 39-400 mg/dl, and every value below 39 mg/dl corresponds to an ‘error code’
reporting that a problem had occurred. At first glance the readings from the two data sets
(described in Chapter 2) show indeed frequent drops of the signals below the lower bound fixed
by Dexcom®. The value displayed by the receiver component in these cases is 9 or 10 mg/dl,
and we shall call invalid output this type of fault. Figure 4.1 depicts an example of CGM signal
corrupted by invalid outputs.
We can speculate that this kind of error depends on the data smoothing activity of the
sensor. Unfortunately, details on filtering strategy used by SEVEN® PLUS are not available
to the public. Nevertheless, assuming that the sensor embeds a moving average filter (or more
generically a finite impulse response filter), the residual between the current datum and the
latest previous samples is evaluated. If the residual is larger than a threshold, then the datum
is considered to be not reliable, and no valid datum is displayed until the residual lowers back
under the threshold [11].
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Figure 4.1 Portion of CGM signal with invalid outputs. The yellow area highlights the four
errors.
4.2 Duration of invalid outputs
Figure 4.2 shows the histogram of the number of faulty samples due to invalid output error. The
actual range of the abscissa is 2-180 samples, but since we recorded few events that involved
just one case each we chose not to depict them. The highest number of invalid outputs (22)
involves only 2 samples, and the histogram suggests that durations exponentially decrease.
On average, an invalid output consisits of 22 samples, i.e. 106.5202 minutes with a standard
deviation of 160.6207, while mode is 2 faulty samples,i.e. 5 minutes, and median is 8 faulty
samples, i.e. 40 minutes.
4.3 Data modeling
In this Section we propose a reasonable model for the CGM signal with which we can explain
the invalid output fault and we will show in Section 4.4 if our idea justified, just as previously
done for disconnections. CGM sensor functioning can be modelled with a two-state Markov
chain, and we redirect the reader to Section 3.3 for a formal definition of a Markov model. In
Figure 4.3 we show the two-state Markov chain we are proposing, with α and β as defined in
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Figure 4.2 Histogram of the number of faulty samples due to invalid output error. The Figure
is focused on the most interesting interval, #1 - #60.
Section 3.3.
4.3.1 Estimate of α
The transition probability α corresponds to the probability of a faulty sample to succeed a
regular one. i.e. it allows us to compute when a failure occurs. Once again, it is estimated as
follows:
αˆ =
# detected faults
# samples observed overall - #faulty samples
. (4.1)
The estimated value is αˆ = 0.0010.
R F 
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Figure 4.3 Two-state Markov model for invalid outputs.
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4.3.2 Estimate of β
The transition probability β corresponds to the probability of a faulty sample to succeed another
faulty sample, i.e. it allows us to compute the duration of the failure once it has already started.
As discussed in Section 3.3.2, given that N is the number of possible durations we found in the
statistical analisys 4.2, we can compute N − 1 probabilities that a disconnection that lasted i
samples, lasts i+ 1 samples. We shall define this probability as:
βˆi =
#[d ≥ i+ 1]
#[d ≥ i] , i = 1, . . . , N − 1. (4.2)
Assuming that the probability to remain in the faulty state does not depend on the duration of an
invalid output, we can evaluate an average value for the transition probability β as follows:
βˆ =
1
N
N∑
i=1
βˆi. (4.3)
The estimated value is βˆ = 0.9727.
In this case as well, we can choose to rely mostly in shorter invalid outputs, where the
sample is larger, and compute the value for the transition probability β e.g. averaging only the
first three values of the {βˆi} set, or the first seven values of the {βˆi} set:
βˆ3 =
1
3
3∑
i=1
βˆi, βˆ7 =
1
7
7∑
i=1
βˆi. (4.4)
We will show in Section 4.4 which one of the three proposed values for β is the most appropriate,
but we have to point out that some other options are also available and not taken into account in
this work: for example, averaging among the {βˆi} can be done with a matrix that weighs the
values differently according to their reliability.
The estimated values for the probabilities defined in Equation 4.4 are βˆ3 = 0.9160 and βˆ7 =
0.9229.
4.4 Validation
In order to validate the model proposed in Section 4.3, we use the same procedure discussed in
Section 3.4. In Figure 4.4 we plot the three curves with equation:
P [d = k] =
α(1− β)
β
βk (4.5)
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Figure 4.4 Graphic validation of the model: the lines drawn with the estimated parameters
αˆ and βˆ do not fit the normalized histogram of invalid outputs’ durations. In the legend are
displayed the three estimated values of βˆ, depending on the confidence we have in the data.
corresponding to the three different values of β estimated in Section 4.3.2.
We can point out that the fit required to the curves is not sufficient for a model validation:
the black one, corresponding to βˆ, is biased by the several long-lasting invalid outputs (more
than 60 faulty samples), while the green and the red curves yet are not a good fit of the data.
Figure 4.5 shows that if we estimate βˆ, βˆ3, βˆ7 considering only short-lasting invalid outputs, i.e.
failures consisting of 2− 21 faulty samples, the model can be considered reasonable and the
curves sim to better fit the data.
Hence, we can conclude that modelling invalid outputs is an open issue, and probably the
model needs to draw a distinction between short and long-lasting invalid outputs. From a
simulation point of view, since we could not infer a proper model, we will draw information
about invalid outputs’ duration from the sampling distribution discussed in Section 4.2.
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Figure 4.5 Graphic validation of the model: the lines drawn with the estimated parameters αˆ
and βˆ fit the normalized histogram of invalid outputs’ durations. In the legend are displayed the
three estimated values of βˆ, estimated considering only short lasting faults (2− 21samples).
4.5 Revising probabilities considering the day and the hour
As previously done for disconnections, we want to investigate whether invalid outputs occur
evenly during the hours of the day and in the several trial days. If this is not so, we will need to
revise transition probability α.
4.5.1 Distribution over the days of experiment
In order to visualize how the disconnection event occurs during the experiment, we plotted the
information about the start of each fault using a histogram as shown in Figure 4.6, left panel.
The highest number of invalid outputs happen during the first 24 hours of insertion (53), and
the second highest amount (32) is found during the last 24 hours. This behaviour reflects that
of a typical electronic device, which bad behaves at the beginning of its operative life, when
defects designed into or built into a product might surface, and at the end of it, because of
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Figure 4.6 Distribution of invalid outputs over the several trial days. Left panel: histogram;
mean: 3.2709, stdev: 2.3107, median: 3.3861. Right panel: probability density function
estimated via kernel density estimation.
the normal wear-and-tear of components in a system. In this particular case, we also have to
consider that the sensor probe needs some time to start its proper measurement because of the
chemical reaction on which it is based [2].
On average, 21.63 invalid outputs occurred every day of the experiment, with a standard
deviation of 15.93.
The right panel of Figure 4.6 shows the probability density function obtained with kernel
density estimation approach, described in Appendix A. The estimation was done at 120 equally
spaced points, with a bandwidth of the kernel smoothing window of 0.9468.
4.5.2 Distribution over 24 hours
As we have previously done in Section 3.5.2 for disconnections, we considered all the errors as
if they occured in one single day. The histogram in the left panel of Figure 4.7 shows that the
highest number of faults (15) occurred at 11pm, and the second highest number (14) at 8am. On
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Figure 4.7 Distribution of invalid outputs over 24 hours. Left panel: histogram; mean:
11.6216, st dev: 7.5320, median: 10.2275. Right panel: probability density function estimated
via kernel density estimation approach.
average, 6.92 invalid outputs are displayed every hour, with a standard deviation of 3.581 and
median 7.
From the histogram we can point out that the errors occur with a higher frequency during
nocturnal hours, as if they were induced by some kind of pressure while the patient is sleeping.
The right panel of Figure 4.7 shows the probability density function obtained with kernel
density estimation approach, described in Appendix A. The estimation was done at 120 equally
spaced points, with a bandwidth of the kernel smoothing window of 0.7414.
4.5.3 Remarks on the trend of the signal before faulty events
We have explored the 3 values of the signal before each invalid output occurred. Of these three
values, mean and derivative were calculated and depicted in a scatter plot (Figure 4.8) in order
to detect any possible correlation. The scatter plot shows that there is no correlation between
the two values, i.e. the trend of the signal previous to the error and the average CGM value at
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Figure 4.8 Scatter plot of mean and derivative of the 3 samples before the error. P-values
and Pearson’s correlation coefficients are also displayed.
which the error occurs are not correlated. The p-value (for testing the null hypothesis of no
correlation) and the Pearson’s correlation coefficient displayed in Figure 4.8 support the result.
In fact, the p-value is the probability of getting a correlation as large as the observed value by
random chance, when the true correlation is zero. If the p-value was small, say less than 0.05,
then the correlation would be significant. In this case, the p-value is 0.3933, hence significantly
larger than 0.05. Moreover, as the Pearson’s correlation coefficient approaches zero there is
less of a relationship (closer to uncorrelated): being R = −0.0653, we can state the absence of
correlation.
This fact simplifies our simulation step since it allows us to consider one parameter less.
4.5.4 Revising transition probability α
As previously done in Section 3.5.3, we want to revise transition probability α, in order to
describe its reliance on the hour and the day of the failure. We redirect the reader to Section
3.5.3 for the procedure, while we quote the result, that involves the estimated value αˆ from
Section 4.3.1:
P [f |DAY = day, HOUR = hour] = 24 · 7 ·P [DAY = day|f ]P [HOUR = hour|f ] · αˆ. (4.6)

5
Analysis of the loss of sensitivity
Two types of CGM failures were discussed so far. The type of CGM failure described
in this Chapter is due to biomechanics, since it arises when a pressure is applied to
the sensor, and we shall call it loss of sensitivity of the CGM signal. Fault identification
was done with visual inspection using BG as a reference when available and led us
to 28 detected failures. The isolation of the faulty shapes was then done exploiting a
bayesian smoothing of the CGM signal, and this procedure also gave us an estimation
of the variance of the measurement error of the signal.
We proposed a model for losses of sensitivity, and estimated its parameters, discussing
their estimation precision as well. Finally, we validated our model showing that it
properly simulates the isolated shapes.
5.1 Main features
The loss of sensitivity is the third type of CGM failure we consider in this work. Its shape is
shown in Figure 5.1: the error consists of a rapid decrease of the signal, followed by an increase
that brings the signal back to the regular trend. This kind of fault was detected comparing the
CGM signal with the reference BG samples when available, and when not, we had to observe
the signal trend in the surroundings of the candidate failure in order to decide if it was so.
For what concerns the reasons that cause a loss of sensitivity, these are related more to
the biomechanics of the sensor-tissue interface has been taken into account rather than to
chemical biocompatibility [12]. Infact, biomechanical factors such as motion and pressure cause
interfacial stresses, which affect tissue physiology around a sensor and, in turn, impact sensor
performance. Motion artifacts can arise when acute forces temporarily impact sensor signal. It
is hypothesized that applying direct pressure on the sensor and surrounding tissue can cause
temporary reduction of localized blood flow, thus perturbing sensor readings. One common
cause of acute motion artifacts is the subject lying or sleeping on the sensor: in humans, pressure
at the sensor site is believed to be responsible for anomalous hypoglicemic measurements
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Figure 5.1 Example of two losses of sensitivity of the CGM signal, highlighted by the pink
area. Blood Glucose samples are used as a reference.
reported at night time, particularly when the patients lie on the sensor [13].
It is relevant to report an example of the acute effects from direct pressure on the sensor, observed
in a clinical trial (details in [14, 15]). CGM readings collected from patient wearing a Dexcom®
SEVEN® PLUS on his abdomen show signal drops as compared to the blood glucose levels, as
the patient laid on the sensor and compressed it.
5.2 Visual Identification
Unlike disconnections and invalid outputs, losses of sensitivity are not well-rendered. Hence,
the identification of these types of fault was done with visual inspection, using BG as a reference
when available. In order to isolate them, we followed this procedure:
1. visual identification of starting and ending point of the loss of sensitivity, exploiting BG
as a reference;
2. removal of the CGM piece affected by the loss of sensitivity identificated at step 1;
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3. interpolation of the CGM signal in the faulty interval that was cleared from the failure at
step 2;
4. the shape of the isolated loss of sensitivity is obtained as the difference between the
interpolated signal and the real CGM values in the faulty interval.
In the first place, we tried a linear interpolation of the CGM signal in the faulty interval (step
3). This technique demonstrated itself to be misleading, since the linear interpolation performs a
rough reconstruction of the CGM signal in the faulty interval, thus spoiling the amplitude of the
resulting isolated fault.
As a consequence, to improve interpolation a bayesian smoothing was applied to the CGM
signal. The procedure is hereinafter discussed, in Section 5.2.1
5.2.1 Bayesian smoothing
We can start by assuming that physiological processes are smooth signals. In order to give a
formal statement of the problem, we define the signal we are dealing with as
y = u+ v (5.1)
where y, u and v are three vectors containing a certain number of CGM measurements, real
(unknown) glycemic values and measurement errors, respectively. The reconstruction of the
real glycemic profile u(t) starting from noisy discrete observations y(t) is a classical smoothing
problem, that can be treated through classical regularization methods. As a consequence, the
first step is to introduce the problem into a stochastic context.
For what concerns Equation 5.1, we can assume, without loss of generality, that v and u are
zero-mean random vectors with Var[v] = σ2Σv, Var[u] = λ2Σu, where Σv and Σu are positive
define matrices, and σ2 and λ2 are positive scalars.
Matrices Σv and Σu express the prior knowledge of the unknown signals v(t) and u(t).
Assuming that the measurement errors are uncorrelated and have the same variance σ2, then the
measurement noise covariance matrix can be written as Σv = σ2I . Furthermore, assuming the
only a priori knowledge on u(t) is that it is a regular biological signal, we can think of it as a
multiple integration of a white noise process. In this way it is easily seen that its covariance
matrix becomes Σu = λ2(F TF )−1. F is a suitable design matrix:
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F = (∆)m (5.2)
where m represents the m-order derivative penalization of the signal u(t) and ∆ is a Toeplitz
matrix:
∆ =

1 0 0 . . . 0
−1 1 0 . . . 0
0 −1 1 . . . 0
. . . 0 −1 . . . . . .
0 . . . . . . . . . 1

(5.3)
The parameter m reflects the degree of smoothness of the signal, and our choice was m = 2, i.e.
we evaluated the second derivative of the signal. We justify this choice referring to [9]. Using
a linear mean-square estimator, given the measurement vector y, our purpose now is to find uˆ
which minimizes E[‖u− uˆ‖2]. The regularization theory says that uˆR is:
uˆR = argmin
uˆ
{
(y − uˆ)T (y − uˆ) + γuˆTF TFuˆ} (5.4)
where the scalar γ = σ2/λ2 > 0 is the so-called regularization parameter. The first term of the
cost function on the right-hand side of equation 5.4 measures the fidelity to the data while the
second term weights the roughness of the estimate. The solution of equation 5.4 is:
uˆR = (I + γF TF )−1y (5.5)
Once m is fixed as previously described, the result is hence a function of the parameter γ.
Nevertheless, in our case, both σ2 and λ2 are unknown.
The estimation procedure for σ2 and λ2 refers to Criterion 2 discussed in [10]. When both
σ2 and λ2 are unknown, the minimization problem of equation 5.4 should be solved for several
trial values of γ = σ2/λ2 until:
WRSS(γ)
n− q(γ) = γ
WESS(γ)
q(γ)
(5.6)
where n is the number of measurements collected in the predetermined interval considered,
WESS(γ):
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Figure 5.2 (a) CGM signal and its bayesian smoothing, with a focus on the faulty pieces. (b)
Isolated losses of sensitivity.
WESS(γ) = uˆTF TFuˆ, (5.7)
is the weighted estimates sum of squares, WRSS(γ):
WRSS(γ) = (y − uˆ)T (y − uˆ), (5.8)
is the weighted residual sum of squares, and q(γ):
q(γ) = trace[In + γF
TF ]−1 (5.9)
which is termed degree of freedom, with In an n-size identity matrix.
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Figure 5.3 Top panel: Boxplot of the estimated values for σ2; red line shows the median;
mean = 8.8; st dev = 3.6; median = 8. Range of the box: 4.8-15.6. Bottom panel: probability
density function estimated via kernel density estimation.
The so-found value of γ maximizes the likelihood of the data. As γ is determined, the
estimations of σ2 and λ2 are given by:
σ2 =
WRSS(γ)
n− q(γ) (5.10)
and
λ2 = σ2/γ. (5.11)
Figure 5.2.1 shows the result of a bayesian smoothing for the CGM signal and an example
of two isolated losses of sensitivity. Along with the isolation procedure, the bayesian smoothing
also gave us an estimate of the variance σ2 of the signals. With this information we can decide
whether a piece of signal is faulty or noisy. We found an average value of the estimated σ2
that is 8.8 mg2/dl2 with a standard deviation of 3.6 mg/dl. Therefore failures smaller than about
2SD ∼= 6 mg/dl were considered to be noise. Figure 5.3 shows the boxplot of the estimated
values for σ2.
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Figure 5.4 Step function with amplitude F and duration D, that is filtered by a first order
system with parameter τ . The overlapped curve shows the result of the filtered signal, with
amplitude A. The time requested by this curve to reach zero is 3τ .
5.3 Data modeling
The model for losses of sensitivity here proposed is based on biomechanical considerations
drawn in Section 5.1, i.e. the failure is due to a transitional pressure applied to the sensor
that acts as a low pass filter. Hence, a good model for this kind of failure is to consider it as
a disturb consisting of a step function filtered by a first order system with transfer function
G(s) = 11+τs . The τ parameter has to be estimated together with the two defining parameters
of the disturb, which are graphically described in Figure 5.3. The step function is characterized
by its amplitude, and we shall call this parameter F, and by its duration D. In the same Figure
we show the shape of a modelled loss, in order to describe the impact of the τ parameter. We
define τ as one third of the time needed by the failure to go from its maximum amplitude (A),
back to zero. The real amplitude A reached by the failure is connected to the amplitude F of the
step function by the relation F = A
1−e−Dτ
.
The equation of the model is:
M(p, t) = −F (1− e−(t+t0)τ )1(t+ t0) + F (1− e
−(t−t0−D)
τ )1(t+ t0 +D) (5.12)
with p = [FDτ ]. We assumed that the parameters we want to estimate do not depend on the
hour of the day, and are mutually indipendent. Our model is non-linear in parameters as shown
by Equation 5.12, hence we solved a non linear least squares problem for each detected and
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isolated fault, in order to find the value:
pˆLS = argmin
pˆ
‖z −M(p)‖2 (5.13)
with z being the faulty isolated CGM profile. Non-linear estimation techniques were used, such
as the iterative method of Gauss-Newton. The algorithm starts with an initial guess for the
minumum, p0, and the method proceeds by the iterations
repeat
• linearization of the model with respect of the parameters of the model, in the surroundings
of pi−1
• solution of the linear least-squares problem gives ∆pˆi
• the latest estimated pˆi = pˆi−1 + ∆pˆi
until
|∆pˆi/pˆi| < tol, with i iteration index and tol a fixed tolerance threshold.
The estimation can be biased by the initial guess, since the iterative procedure might fall into
a local, rather than absolute, minumum of the function. The starting vector p0 = [F0 D0 τ0]
for the algorithm was chosen as the average values of the same parameters evaluated for the
isolated losses.
5.3.1 Precision and Statistics of the estimated parameters
The solution of the non-linear least squares problem we have previously discussed, gives us
the Jacobian matrix J of the minimized function at the estimated vector pˆ. In this case, we can
define the covariance matrix Σp in order to measure the estimation error:
Σp ∼= (JTΣ−1v J)−1. (5.14)
In our case, to each patient whose CGM signal is affected by losses of sensitivity corresponds
one matrix Σ−1v defined as
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Σ−1v =

1/σ2 0 0 . . . 0
0 1/σ2 0 . . .
...
... 0
. . . . . .
...
... 0 0
. . .
...
0 . . . . . . . . . 1/σ2

(5.15)
- with σ2 estimated along with the bayesian smoothing as discussed in Section 5.2.1. Hence,
for each one of the detected and isolated fault, we can compute the estimation precision of the
parameters using equation 5.14. Table 5.3.2 shows this result, highlighting those parameters
whose estimation precision is bad, while Table 5.3.2 shows five interesting parameters that
describe the goodness of fit for each simulated loss of sensitivity.
For what concerns failures 3, 4 and 10 shown in Figure 5.3.2, we can see that the the yellow
area of ±2 · confidence interval is large and the amplitudes of the isolated shapes are small.
Hence, a simpler model as well would predict a proper shape, while here we obtain bad results
for FIT parameters. Moreover, the isolated shapes are less similar to the expected one shown
in Figure 5.3, hence the empirical evaluation of F0, D0 and τ0 is less significant and gives bad
estimation precisions. We show in Figure 5.3.2 the original CGM signal where we isolated the
three failures we are discussing, in order to demonstrate that our visual detection was right, but
something spoiled the result during the isolation procedure.
Figure 5.3.2 shows other failures that are worth a further insight. Loss of sensitivity 12 is
simulated by the model with bad values for both MSE and FIT, even though the estimation
precision of the parameters of the model is good. The MSE is very high in this case because
our model simulates failures starting from a zero glycemic level, while the isolation procedure
does not always assure this. Also failure 22 is simulated with a bad FIT and good estimation
precision of the parameters, because its shape is irregular and hard for the model to follow.
Failure 16 instead is made of only 3 samples, hence the estimation of the 3 parameters of the
model on such little data is understandably hard, giving bad estimation precision and yet very
good FIT. Failure 24 has a very irregular shape that is hard for our model to follow, and lastly
failure 25 behaves in the opposite way of what we expect, since we have described the loss of
sensitivity as a rapid decrease of the signal (5.1).
We consider the other estimation precisions to be reasonably good.
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Figure 5.5 Scatter plot of the estimated parameters (F , τ ), (D, τ ), (F , D). P-values and
Pearson’s correlation coefficients are also displayed.
Figure 5.8 shows the histogram and the density function obtained via kernel density esti-
mation for both initial parameters p0 = [F0 D0 τ0] and the estimated ones pˆ = [F D τ ].
We found that the estimated parameter D, i.e. the time needed to reach the maximum amplitude
A, is on average 21.3 minutes, while the estimated amplitude of the step function F is on
average −41.8 mg/dl. The system parameter τ is on average 13.5 minutes.
We also tried to run the estimation algorithm with the same common initial guess p0 for all
faults. The vector p0 was chosen as the average of the empirical evaluated parameters F , D
and τ on each isolated fault, as described in Figure 5.3. The statistics results for the estimated
parameters is shown in Figure 5.9, in comparison to the previous estimation results displayed in
Figure 5.8. This result demonstrates that our estimation method is robust to the initial guess.
5.3.2 Correlation between F , D and τ
In Section 5.3 we made two assumption. The first deals with the relationship between the failure
and the moment of its occurrence: this issue will be explored in Section 5.5. The second is about
the statistical relationship between the three parameters D, F , τ . We investigated this issue
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with a scatter plot for each of the couples (F , τ ), (D, τ ), (F , D) and evaluating the p-value, for
testing the null hypothesis of no correlation, and the Pearson’s correlation coefficient R (we
refer the reader to Section 4.5.3 for the meaning of p-value and R). Figure 5.5 shows this result.
For what concerns the couples (D, τ ) and (F , D), in both cases the p-value is larger than
0.05 hence we can support the null hypothesis of no correlation. For couple (F , τ ) instead, the
p-value is lower than the threshold of 0.05, but |R| < 0.5, hence we can say that these two
parameters are partially correlated.
5.4 Validation
A first validation of the model we have previously described is given in Figure 5.4. We show
here with two examples that simulating the loss of sensitivity with this model leads us to a
signal that is similar to the isolated real failure, and is inside the area of ±2 · confidence interval,
which is obtained with the previously estimated σ2, as discussed in Section 5.2.1. The other
simulated losses of sensitivity are shown in Appendix B.
Furthermore, we chose pieces of CGM signal in which we had found no failure, and removed
them as described in Section 5.2. The whole signal then underwent bayesian smoothing, and
we expected the reconstructed signal to lie within the ±3 · confidence interval obtained with
the estimated σ2. Figure 5.4 shows four examples of the smoothed signal lying within the
±3 · confidence interval , which proves that isolating pieces of regular signal is not misleading.
5.5 Reliance on the hour and the day of experiment
As previously done for disconnections and invalid outputs, we wonder if transition probability
αˆ should be revised considering the hour and the day at which failure occurs. Figure 5.12 shows
the result for the distribution of losses of sensitivity over 24 hours and through the several days
of experiment. Considering that we found a small amount of pressure faults (28), we are not
revising the transition probability because we cannot gather significant information from such a
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# loss MSE FIT (%) COD (%) VAPNIK VAPNIK FIT
(%)
1 4.4489 72.8399 92.6233 0.2583 93.2634
2 5.3979 58.6935 82.9377 0.11576 94.4345
3 20.0696 14.9614 27.6844 0 0
0
4 2.8256 59.3382 83.4662 0 0
0
5 17.2726 74.1279 93.3063 0 100
6 4.436 85.7085 97.9575 0 100
7 35.0123 60.8489 84.6719 0 0
0
8 35.5277 77.8835 95.1086 0 100
9 35.7024 68.6243 90.1557 0.54073 93.6721
10 24.0505 42.1049 66.4815 0 100
11 8.2897 77.0703 94.7423 0 100
12 20.036 29.5094 50.3107 0.69486 35.9385
13 6.9514 63.7941 86.8913 0.19665 94.9374
14 41.4536 41.8388 66.1728 1.5071 69.8901
15 13.2339 65.0399 87.7779 0.0042032 99.9129
16 0.2031 93.3686 99.5602 0 100
17 11.651 67.5585 89.4755 0.16306 96.6248
18 7.1542 70.5571 91.3312 0.14547 96.1511
19 4.9779 71.6762 91.9776 0 100
20 7.5477 72.7415 92.5697 0.13071 97.3613
21 20.5042 77.0219 94.7201 1.2697 90.5562
22 29.8898 32.6935 54.6983 0.57873 63.1904
23 0.67519 84.621 97.6349 0 0
0
24 11.348 39.0962 62.9073 0.50938 62.1821
25 41.7089 16.6987 30.6089 1.6655 34.6656
26 6.2978 71.049 91.6184 0 100
27 6.234 77.4247 94.9035 0 100
28 31.6266 75.6968 94.0935 1.4953 90.3779
Table 5.1 Interesting parameters describing the goodness of our model.
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# loss F (mg/dl), (%) D (min), (%) τ (min), (%)
1 -28.3, 7 22.3, 5 6.6, 18
2 -11.2, 20 12.7, 19 2.8, 73
3 -6, 646 20, 337 16.7, 1036
4 -78.4, 168 5.6, 95 26.3, 171
5 -73.5, 14 11.3, 10 9.4, 20
6 -36.6, 7 39.1, 3 7.4, 22
7 -38.4, 70 20.9, 54 10, 142
8 -104.3, 35 20.2, 25 14, 54
9 -68.8, 7 22.2, 6 6.9, 19
10 -40, 329 17.6, 77 46.8, 377
11 -43.8, 11 18.5, 6 8.2, 21
12 -22.5, 22 12.3, 20 3.6, 64
13 -34.1, 11 18, 6 17.1, 13
14 -20, 11 35, 9 11.1, 27
15 -27.5, 12 24, 6 9.3, 23
16 -14.9, 109 4.9, 109 1.2, 109
17 -35, 9 29.1, 5 13.2, 15
18 -246, 6 37.2, 4 9.2, 17
19 -23.7, 12 28.2, 6 8.8, 25
20 -33.6, 13 26.3, 8 16.2, 23
21 -82.2, 12 15, 13 14.3, 15
22 -128.3, 20 10.2, 13 39.5, 19
23 -19.7, 54 12.1, 38 6.4, 100
24 -25.2, 115 26.3, 27 39.1, 149
25 -5.7, 18 40.1, 1011 0.5, 1011
26 -32.6, 15 18.9, 8 9.4, 25
27 -31.3, 11 24.2, 5 8, 22
28 -79.3, 8 25, 5 15, 14
Table 5.2 Estimated parameters F, D, τ described in Section 5.3 and their estimation preci-
sion. The grey shadow highlights those parameters whose estimation precision is bad.
50 Chapter 5. Analysis of the loss of sensitivity
0 5 10 15 20 25 30
-30
-20
-10
0
10
20
30
Time (minutes)
G
lu
c
o
s
e
 (
m
g
/d
L
)
3
 
 
sim with p
0
sim with p
est
data
0 5 10 15 20 25 30
-40
-30
-20
-10
0
10
20
Time (minutes)
G
lu
c
o
s
e
 (
m
g
/d
L
)
4
 
 
sim with p
0
sim with p
est
data
0 5 10 15 20 25 30
-30
-25
-20
-15
-10
-5
0
5
10
15
20
Time (minutes)
G
lu
c
o
s
e
 (
m
g
/d
L
)
10
 
 
sim with p
0
sim with p
est
data
1060 1080 1100 1120 1140 1160 1180 1200 1220 1240
265
270
275
280
285
290
295
300
305
310
X: 1202
Y: 281.3
Time (minutes)
Gl
uc
os
e 
(m
g/
dL
)
X: 1169
Y: 277
X: 1127
Y: 274.5
X: 1095
Y: 271.7
5050 5100 5150 5200 5250 5300 5350
100
120
140
160
180
200
220
X: 5207
Y: 147.2
Time (minutes)
G
lu
c
o
s
e
 (
m
g
/d
L
)
X: 5173
Y: 142.5
Figure 5.6 Losses of sensitivity that gave bad estimation precision for the parameters F , D
and τ .
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Figure 5.7 Losses of sensitivity that are worth a careful evaluation.
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Figure 5.8 Statistics of parameters F,D, τ : histogram and probability density function
obtained via kernel density estimation for p0 and pˆ. (a) F0:mean: -35.36, median: -29.76, st
dev: 21.14, Fest:mean: -41.78, median: -33.08, st dev: 30.3; (b) D0:mean: 18.43, median: 17.5,
st dev: 8.79, Dest:mean: 21.33, median: 20.56, st dev: 9.36; (c) τ0:mean: 6.46, median: 5, st
dev: 3.91, τest:mean: 13.46, median: 9.41, st dev: 11.41.
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Figure 5.9 Robustness of the estimation of model parameters to the initial guess. The red
lines represent the probability density function of estimated parameters as discussed in Section
5.3.1 and shown in Figure 5.8.
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small sample. This matches our assumption in Section 5.3.
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Figure 5.10 Simulating two losses of sensitivity with the discussed model. The yellow area
highlights the ±2 · confidence interval, the blue line represents the isolated failure from the real
CGM data, the green line is the result with the best estimation of the parameters pˆ. The red line
shows the simulated signal with the initial guess p0, defined in Section 5.3.
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Figure 5.11 The red lines show pieces of CGM signal with no failures, the black lines show
the result for the bayesian smoothing obtained as described in Section 5.4, the yellow area
highlights the ±2 · confidence interval.
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Figure 5.12 (a): Distribution of losses of sensitivity over the several trial days. Left panel:
histogram; mean: 2.1367, stdev: 1.5519, median: 2.0259. Right panel: probability density
function estimated via kernel density estimation. (b): Distribution of losses of sensitivity over
24 hours. Left panel: histogram; mean: 14.0718, st dev: 6.7086, median: 14.9315. Right panel:
probability density function estimated via kernel density estimation approach.
6
Simulation of CGM faults
In the previous chapters we have shown how to simulate three of the most common
failures one can detect in CGM real data. In this chapter, we show the results of the
simulated failures, and add them to glycemic profiles obtained with the Simulator GIM.
Testing control algorithms needs to cope with the most common failures one can find
in CGM real data, hence we provide simulation tools that can be embedded with the
simulated sensor block of the Simulator GIM.
6.1 Dalla Man et al. model
One of the most important application of CGM sensors is the Artificial Pancreas. The develop-
ment of the Artificial Pancreas was largely enhanced by the Simulator of the human metabolism,
i.e. the Glucose-Insulin Model (GIM) [16, 17]. This software realizes in silico mathematical
models for both the diabetic patient and hardware components that take part in the closed loop
control of glycemia in the Artificial Pancreas, i.e. the CGM sensor and the insulin pump. GIM
is used by the researchers in order to develop and validate control algorithms, which saves time
and money. In fact, this software was approved by Food and Drug Administration, the agency of
the USA responsible for regulation and supervision of food and drug, as a substitute for animal
trials. Hence, since 2008 control algorithms can be tested directly on human beings with no
intermediate steps.
6.2 Simulation of disconnections
Exploiting the model described in Chapter 3, we discuss in this Section the results of a discon-
nections’ simulation over 100 of 7-days lasting signals.
Figure 6.2 shows the statistical analysis of both the simulated disconnections and the real
ones. For what concerns failures’ duration, we can see from the histogram in the Figure (a) that
the estimated βˆ chosen in Section 3.3.2 gives a distribution of simulated disconnections similar
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to the real one.
Panel (b) and (c) of Figure 6.2 show the probability density function obtained via kernel
density estimation for failures’ occurances during the 24 hours and sensor life. From these
results, we can see that while for the 24 hours period we obtain a probability density function
similar to the real one, for the 7days period this does not happen. Infact, we used the revised
probability αˆ, discussed in Section 3.5.3, but this is not a proper choice, since the probability
for a failure to happen at one specific hour of the day is not independent from the probability for
a failure to happen in one specific day of sensor life. Moreover, the probability density function
estimated in Section 3.5.1 describes failures’ occurances during sensor life, regardless of the
real hour of the day.
6.3 Simulation of invalid outputs
As previously done for disconnections, we are here simulating invalid outputs as discussed in
Section 4.4. We show the results for a simulation of 100 7-days lasting signals.
Figure 6.3 (a) shows the two histograms for simulated (left panel) and real (right panel)
invalid outputs, with a focus in durations smaller than 60 samples. As discussed in Section 4.4,
the information about durations was drawn from the sampling distribution of real failures, hence
we can see that the two results are significantly similar.
Panel (b) and (c) of Figure 6.3 show the probability density function obtained via kernel
density estimation for failures’ occurances during the 24 hours and sensor life. In both cases, we
see that the simulated distributions are similar to the real ones, demonstrating that our simulation
procedure is correct.
6.4 Simulation of losses of sensitivity
Finally, we want to show that we could simulate losses of sensitivity as well. In order to choose
the parameters F , D and τ , we used the statistical information of the estimated parameters.
Figure 6.4 shows that we obtained simulated probability density functions of the simulated
parameters similar to the real ones.
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Figure 6.1 (a) Left panel: durations’ distribution of simulated disconnections. Right panel:
durations’ distribution of detected disconnections. (b) The distribution of simulated disconnec-
tions over the 24 hours (black curve) is very close of the real distribution (grey curve). (c) The
distribution of simulated disconnections in the several days (black curve) is different from the
real one (grey curve).
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Figure 6.2 (a) Left panel: durations’ distribution of simulated invalid outputs. Right panel:
durations’ distribution of detected invalid outputs. (b)-(c) In both cases, the distribution of
simulated invalid outputs over the 24 hours and the several days (black curve) is very close of
the real distribution (grey curve).
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Figure 6.3 Probability density function of simulated parameters F , D and τ compared to
the real ones.
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Figure 6.4 Simulation of an invalid output, a loss of sensitivity and a disconnection on a
virtual diabetic patient.
6.5 Simulated failures applied to simulated CGM profile
Our purpose is to improve the simulated sensor block in the GIM simulator. Hence, adding the
simulated failures to the simulated glycemic profiles, we can realize CGM profiles more similar
to the real ones, so that robustness tests of control algorithms are more reliable.
Figure 6.5 an example of simulated diabetic (type-1) patient, and the scenario is:
• breakfast at 7 a.m. with 40 g of carbohydrates;
• lunch at 1 p.m. with 70 g of carbohydrates;
• dinner at 8 p.m with 80 g of carbohydrates.
7
Conclusions
CGM sensors are useful devices that supply several advantages and allow the development of
important applications for diabetes management, such as the Artificial Pancreas. In order to
test these applications, it is often used a physiological simulator of type-1 diabetic patient, that
provides CGM simulated data for virtual patients. Nevertheless, these simulated profiles are not
provided with the common failures we find instead in the real CGM signals (Dexcom® in this
thesis), such as those we discussed in Chapters 3, 4 and 5. The closer simulated profiles are to
the real ones, the more reliable are the testing results of these applications.
An investigation of the available data set led us to identify three main kinds of failures.
The first one, we called disconnection, consists of the loss of at least one sample during the
transmission of the signal between transmitter and receiver. We proposed and validated a
two-state markov model for this failure. The same model did not work for the second kind
of failure, which is an ‘error code’ displayed by the receiver, called invalid output. The third
failure we discussed is the loss of sensitivity, which was modelled as a step function filtered by
a first order system. We could simulate disconnections and losses of sensitivity and add the
result at the output signal of the simulator, in order to obtain more realistic CGM profiles. For
invalid outputs, we had to draw information from the empiric distribution since the model was
not appropriate.
For what concerns disconnections, we obtained a simulation tool that is ready for use.
Losses of sensitivity as well were described and simulated with a proper model, but still we can
emphasize some open issues where there is substantial room for improvement:
1. failures’ visual inspection is biased by the arbitrariness of the choice of starting and
ending points;
2. different interpolation techniques should be investigated, other than linear interpolation
and bayesian smoothing, since this step of the isolation procedure determines the shape
of the failure;
3. only a small amount of losses of sensitivity were found, hence a larger data set should
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be exploited in order to make our model more robust and statistically analyze time
occurances.
Lastly, the model proposed for invalid outputs did not satisfy our validation criteria, hence we
suggest two possible ways:
1. distinguishing between long and short-lasting invalid outputs, and modelling them sepa-
rately;
2. testing a two-exponential model to describe both long and short-lasting invalid outputs.
Sharing information about ‘error codes’ with manufacturing companies might be useful.
A
Kernel Density Estimation
The objective of many investigation is to estimate the probability density function (pdf), f(x),
from a sample of observation x1, x2, · · · , xn.
The parametric approach for estimating f(x) is to assume that f(x) is a member of some
parametric family of distributions, e.g. N(µ, σ2), and then to estimate the parameters of the
assumed distribution from the data. This approach has advantages as long as the distributional
assumption is correct, or at least is not seriously wrong. The main disadvantage of the parametric
approach is lack of flexibility. Each parametric family of distributions imposes restrictions on
the shapes that f(x) can have. For example the density function of the normal distribution is
symmetrical and bell-shaped, and therefore is unsuitable for representing skewed densities or
bimodal densities.
Methods that attempt to estimate the density directly from the data without assuming a
particular form for the underlying distribution are called non-parametric. The simplest form of
non-parametric estimation is the histogram, but it has several drawbacks, such as:
• the discontinuities of the estimate are an artifact of the chosen bin locations;
• the density estimate depends on the starting position of the bins.
Nevertheless, the histogram is useful for quick visualizations.
Kernel density estimation helps dealing with the two drawbacks we have just discussed.
From the definition of the pdf, f(x), of a random variable, X , one has that
P (x− h < X < x+ h) =
∫ x+h
x−h
f(t)dt ≈ 2hf(x)
and hence
f(x) ≈ 1
2h
P (x− h < X < x+ h) (A.1)
The probability in A.1 can be estimated:
fˆ(x) =
1
2h
number of observation in(x− h, x+ h)
n
(A.2)
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and A.2 can be represented this way as well
fˆ(x) =
1
n
n∑
i=1
w(x− xi, h), (A.3)
where x1, x2, · · ·xn are the realizations of the random variable and
w(t, h) =

1
2h , for |t| < h
0, otherwise
The function defined in A.3 has the properties of a pdf, i.e. fˆ(x) is non-negative for all x
and the area between the x-axis and fˆ(x) is equal to one. One way to interpret A.3 is to imagine
that a rectangle (height 12h and width 2h) is placed over each observed point on the x-axis. The
estimate of the pdf at a given point is 1n times the sum of the heights of all the rectangles that
cover the point. By increasing h one increases the width of each rectangle and thereby increases
the degree of smoothing.
Instead of rectangles, other weighting functions can be used, e.g. triangles:
w(t, h) =

1
h(1− |t|h ), for |t| < h
0, otherwise
Using triangles in A.3 once again makes fˆ(x) a pdf, and increasing h increases the degree of
smoothing here too.
Another weighting function is the Gaussian:
w(t, h) =
1√
2pi
e−t
2/2h2 , −∞ < t <∞
In this case as well, increasing h implies a more regular fˆ(x).
All the weighting functions w(t, h) are of the form
w(t, h) =
1
h
K(
t
h
), (A.4)
where K is a function of the variable t and is called kernel. A kernel is a standardized weighting
function, namely the weighting function with h = 1. The kernel determines the shape of
the weighting function. The parameter h is called the bandwidth or smoothing constant. It
determines the amount of smoothing applied in estimating f(x), i.e. the wider h is, the smoother
the estimate fˆ(x). For h→ 0, the kernel approaches a Dirac delta function, and fˆ(x) approaches
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the true density. However, in practice we have a finite number of points, so h cannot be made
arbitrarily small, since the density estimate fˆ(x) would then degenerate to a set of impulses
located at the training data points.
In general any function having the following properties can be used as a kernel:
(a) ∫
K(z)dz = 1
(b) ∫
zK(z)dz = 0
(c) ∫
z2K(z)dz := k2 <∞
It follows that any symmetric pdf is a kernel. However, non-pdf kernels can also be used,
e.g. kernels for which K(z) < 0 for some values of z. The latter type of kernels have the
disadvantage that fˆ(x) may be negative for some values of x.
Kernel estimation of pdfs is charactized by the kernel, K, which determines the shape of the
weighting function, and the bandwidth, h, which determines the width of the weighting function
and hence the amount of smoothing. The two components determine the properties of fˆ(x).
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Figure B.1 Simulated losses of sensitivity with the model. The yellow area highlights the
confidence interval, the blue line represents the isolated failure from the real CGM data, the
green line is the result with the best estimation of the parameters pˆ.
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